DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rituxan (Rituximab) - Current Clinical Trials

 
 



Rituxan Related Clinical Trials

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients [Active, not recruiting]

Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma [Active, not recruiting]

Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102) [Completed]

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-Matched Related HSCT [Active, not recruiting]

Safety Study of Rituximab (Rituxan®) in Chronic Urticaria [Suspended]

SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) [Active, not recruiting]

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL [Active, not recruiting]

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker. [Active, not recruiting]

Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma [Active, not recruiting]

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Recruiting]

Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma [Active, not recruiting]

Safety and Efficacy Study of Re-Treatment With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNFα Therapies [Active, not recruiting]

Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL [Terminated]

Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation [Recruiting]

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL) [Terminated]

Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma [Recruiting]

Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus [Recruiting]

A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma [Recruiting]

Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura [Recruiting]

Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab [Active, not recruiting]

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia [Recruiting]

Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease [Recruiting]

A Study of MabThera (Rituximab) Subcutaneous Vs. MabThera (Rituximab) Intravenous in Patients With Follicular Non-Hodgkin's Lymphoma [Recruiting]

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis [Recruiting]

MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. [Active, not recruiting]

Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Recruiting]

Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia [Recruiting]

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Recruiting]

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia [Recruiting]

A Study of Patient Preference With Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Patients With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a [Recruiting]

A Study on The Safety of Administering MabThera/Rituxan (Rituximab) at A More Rapid Rate in Patients With Rheumatoid Arthritis (RATE-RA) [Recruiting]

Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL [Recruiting]

A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma [Recruiting]

An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC) [Recruiting]

TREatment of degeNerative and Neoplastic Diseases With Rituximab [Recruiting]

Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic [Recruiting]

Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma [Recruiting]

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia [Recruiting]

Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Recruiting]

A Study of DCDT2980S in Combination With MabThera/Rituxan or DCDS4501A in Combination With MabThera/Rituxan in Patients With Non-Hodgkin's Lymphoma [Recruiting]

A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma [Recruiting]

Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) [Not yet recruiting]

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant [Recruiting]

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma or CLL [Not yet recruiting]

A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR) [Recruiting]

A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis

A Study to Evaluate Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin’s Lymphoma [Terminated]

A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma [Active, not recruiting]

Study Comparing Inotuzumab Ozogamicin in Combination With Rituximab Versus Defined Investigator's Choice in Follicular Non-Hodgkin's Lymphoma (NHL) [Recruiting]

Phase II Trial of Rituximab Plus Sargramostim for Newly Diagnosed Follicular B-Cell Lymphoma in Adults [Recruiting]

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma [No longer recruiting]

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone [Withdrawn]

Primary Rituximab and Maintenance [Completed]

A Study to Evaluate the Efficacy and Safety of Rituximab in Patients With Severe Systemic Lupus Erythematosus (EXPLORER) [Active, not recruiting]

A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies. [Active, not recruiting]

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen [Recruiting]

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma [Terminated]

A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura. [Recruiting]

A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis. [No longer recruiting]

A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA) [Recruiting]

Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan [Active, not recruiting]

A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor [Not yet recruiting]

Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia [Recruiting]

A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis [No longer recruiting]

Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis [Not yet recruiting]

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia [Active, not recruiting]

Rituximab+Standard CHOP vs Rituximab+bi-Weekly CHOP for Untreated Stage III/IV Low-Grade B-Cell Lymphoma (JCOG0203) [Active, not recruiting]

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma [Terminated]

A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate [No longer recruiting]

Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma [Completed]

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy [Terminated]

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. [Recruiting]

Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL [Recruiting]

A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma [No longer recruiting]

A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA) [No longer recruiting]

Comparison of Two Induction Combination Chemotherapy Regimens Followed By High-Dose Consolidation Chemotherapy and Autologous Stem Cell Transplantation With or Without Rituximab as Maintenance Therapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Recruiting]

Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia [Completed]

Rituximab to Treat Neuropathy With Anti-MAG Antibodies [Completed]

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma [Terminated]

Rituximab to Treat Stiff Person Syndrome [No longer recruiting]

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma [Terminated]

A Comparison Of Rituximab vs. Iodine I 131 Tositumomab Therapeutic Regimen (i.e., BEXXAR) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma [Active, not recruiting]

Effectiveness of Rituximab in Pediatric OMS Patients. [No longer recruiting]

Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy [Terminated]

Rituximab as Second Line Treatment for ITP [Recruiting]

Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis [Completed]

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Recruiting]

Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia [Active, not recruiting]

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia [No longer recruiting]

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [No longer recruiting]

Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis [Recruiting]

Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease [No longer recruiting]

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia [Active, not recruiting]

A Pilot Trial of Rituxan in Refractory Myasthenia Gravis [Recruiting]

CC-5013 and Rituximab in Waldenstrom's Macroglobulinemia [No longer recruiting]

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-Cell Lymphoma [Terminated]

Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012